본문 바로가기

Serum CCL11 level is associated with radiographic spinal damage in patients with ankylosing spondylitis

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q2
저널
RHEUMATOLOGY INTERNATIONAL38(8) · pp.1455 · 2018
피인용
Web of Science 11Scopus 11
FWCI (Scopus)
0.46
JCR IF
JCR 2017 1.952
ISSN
0172-8172

저자

  1. 손동현제1저자Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, South Korea
  2. 정호임Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, South Korea
  3. 노종성Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, South Korea
  4. 이한나Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea
  5. 김은성Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea
  6. 고정희Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea
  7. 이승근교신저자Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea

초록

The clinical significance of C-C motif chemokine11 (CCL11) in bone metabolism in ankylosing spondylitis (AS) is not clearly elucidated. Thus, this cross-sectional study aimed to compare serum levels of CCL11 between patients with AS and healthy controls and to investigate the relationship between serum levels of CCL11 and radiographic spinal damage in patients with AS. We consecutively recruited 55 male patients with AS and 26 age- and sex-matched healthy controls. Serum levels of CCL11, tumor necrosis factor-alpha (TNF-alpha), interleukin-17, and Dickkopf-1 (DKK-1) were measured with commercially available enzyme-linked immunosorbent assay kits. Radiographs were scored according to the modified Stoke ankylosing spondylitis spine score (mSASSS), and syndesmophytes were defined as mSASSS ae<yen> 2. The serum levels of CCL11 in AS patients with syndesmophytes were significantly higher than those in AS patients without syndesmophytes (p = 0.007) and healthy controls (p = 0.006). In AS patients, the serum levels of CCL11 were significantly and positively correlated with mSASSS (p = 0.006), number of syndesmophytes (p = 0.029). After adjusting for confounding factors, elevated serum levels of CCL11 were associated with increased mSASSS (beta = 0.007, p = 0.03) and higher risk for the presence of syndesmophytes (OR 2.34 per 50 pg/ml increase, p = 0.012) in AS patients. We found that the serum level of CCL11 was associated with structural damage in patients with AS, suggesting that CCL11 may serve as a promising biomarker for new bone formation in AS.

키워드

Ankylosing spondylitisCC chemokinesOsteogenesisBiomarkersTumor necrosis factorFIBROBLAST-LIKE SYNOVIOCYTESUP-REGULATED EXPRESSIONAXIAL SPONDYLOARTHRITISRHEUMATOID-ARTHRITISOSTEOPOROSISBIOMARKERSDIAGNOSISCELLSDIFFERENTIATIONSCHIZOPHRENIA

식별자

Scopus EID
2-s2.0-85047815824
WoS UID
000438624900014